| Abbreviation | Meaning |
| 17β | hydroxysteroid dehydrogenase type 1 |
| 3β | hydroxysteroid dehydrogenase |
| ARs | androgen receptors |
| ARO | aromatase |
| BALF | bronchoalveolar lavage fluid |
| BMDCs | bone marrow-derived dendritic cells |
| CSCs | cancer stem cells |
| CXCR4 C-X-C chemokine receptor type 4 | |
| CYP17 | 17aα-hydroxylase |
| CYP19A1 | aromatase |
| DCs | dendritic cells |
| DHEA | dehydroepiandrosterone |
| DHEAS | dehydroepiandrosterone sulfate |
| DHT | 5α-dihydrotestosterone |
| E1 | estrone |
| E2 | 17β-estradiol |
| E3 | estriol |
| EGFR | epidermal growth factor receptor |
| EGFR-TKIs | epidermal growth factor receptor-tyrosine kinase inhibitors |
| EMT | epithelial-mesenchymal transition |
| ERs | estrogen receptors |
| ERα, ER1 | estrogen receptor α |
| ERβ, ER2 | estrogen receptor β |
| ESR1 | estrogen receptor alpha gene |
| ESR2 | estrogen receptor beta gene |
| EVs | extracellular vesicles |
| G-CSF | granulocyte colony-stimulating factor |
| GPER1 | G protein-coupled estrogen receptor 1 |
| HDACi | histone deacetylase inhibitors |
| HER2 | human epidermal growth factor receptor 2 |
| HGPIN | high-grade prostatic intraepithelial neoplasia |
| HR+ | hormone-positive |
| HRT | hormonal replacement therapy |
| ICIs | immune checkpoint inhibitors |
| IL | interleukin |
| LAG-3 | lymphocyte activation gene 3 |
| LNs | lymph nodes |
| LPS | lipopolysaccharide |
| MAPK | mitogen-activated protein kinase |
| MDSCs | myeloid-derived suppressor cells |
| MMP-2 | matrix metalloproteinase-2 |
| MMP-9 | matrix metalloproteinase-9 |
| MPs | microparticles |
| NO | nitric oxide |
| NSCLC | non-small cell lung carcinoma |
| OS | overall survival |
| P450scc | cytochrome P450 side-chain cleavage enzyme |
| PBMC | peripheral blood mononuclear cell |
| PD-L1 | programmed death ligand 1 |
| SASP | senescence-associated secretory phenotype |
| SCLC | small cell lung carcinoma |
| SHBG | sex hormone-binding protein |
| SNPs | single-nucleotide polymorphism |
| STS | steroid sulfatase |
| TAMs | tumor-associated macrophages |
| TES | testosterone |
| TEXs | tumor-derived exosomes |
| TILs | tumor-infiltrating lymphocytes |
| TIM3 | T-cell immunoglobulin and mucin domain-containing molecule 3 |
| TKIs | tyrosine kinase inhibitors |
| TMB | tumor mutational burden |
| TME | tumor microenvironment |
| TNBC | triple-negative breast cancer |
| TNFα | tumor necrosis factor α |
| VEGF | vascular endothelial growth factor |
| VISTA | V-domain Ig suppressor of T-cell activation |